Related Experiment Video

Updated: Aug 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Atypical pneumonias in children

M R Hammerschlag1

  • 1Department of Pediatrics, SUNY Health Science Center, Brooklyn, USA.

Advances in Pediatric Infectious Diseases
|January 1, 1995
PubMed

Insights

Atypical pneumonia in children is often caused by Mycoplasma pneumoniae and Chlamydia pneumoniae. Early recognition and appropriate antibiotic treatment, such as macrolides, are crucial for effective management.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Atypical pneumonia in children is caused by diverse pathogens, including Mycoplasma and Chlamydia species.
  • Mycoplasma pneumoniae and Chlamydia pneumoniae are significant contributors, potentially causing over 40% of cases.
  • Standard diagnostic methods for these atypical pathogens are often unavailable in hospital laboratories.

Purpose of the Study:

  • To highlight the importance of recognizing atypical pneumonia agents in children.
  • To emphasize the role of epidemiologic factors in diagnosing less common infections.
  • To guide appropriate antibiotic selection for atypical pneumonia.

Main Methods:

  • Review of causative agents of atypical pneumonia in pediatric populations.
  • Analysis of diagnostic challenges and limitations in routine microbiology.
  • Correlation of epidemiological clues with specific etiological agents.

Main Results:

  • Mycoplasma pneumoniae and Chlamydia pneumoniae are leading causes of atypical pneumonia in children.
  • Clinical diagnosis is often challenging, necessitating consideration of epidemiological data.
  • Failure to respond to beta-lactam antibiotics suggests atypical pathogens.

Conclusions:

  • Epidemiological history is vital for suspecting specific atypical pneumonia agents.
  • Macrolides are recommended as first-line antibiotics for Mycoplasma and Chlamydia pneumoniae infections in children.
  • Timely diagnosis and targeted therapy are essential for improved outcomes in pediatric atypical pneumonia.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...